From November 14 to 16, 2024, the 26th Academic Conference of the Chinese Diabetes Society, co-hosted by the Chinese Medical Association and its Diabetes Society, and organized by the Jiangsu Medical Association, was held in Nanjing. Themed 「Focusing on the Frontier, Standardizing Management, and Empowering Primary Care」, the conference invited leading experts and scholars in the field of diabetes to present cutting-edge reports, foster interdisciplinary dialogue, and conduct practical skills training for grassroots healthcare professionals based on clinical guidelines, aiming to enhance the diagnosis and treatment capabilities in diabetes care at the primary level.

At the conference, TUL shared its development plans for antidiabetic biologics with experts and scholars through product displays, presentations on innovative drugs in development, distribution of promotional materials, and interactive games, demonstrating its long-term strategic vision in the field of diabetes treatment.